Literature DB >> 22734298

Evaluation of device-associated infections in a neonatal intensive care unit.

Mehmet Yalaz1, Ozge Altun-Köroğlu, Behiye Ulusoy, Başak Yildiz, Mete Akisu, Fadil Vardar, Mehmet Ali Ozinel, Nilgün Kültürsay.   

Abstract

Device-associated infections are common in Neonatal Intensive Care Units (NICUs) in accordance with the frequent use of invasive devices, and they must be continuously and closely monitored for infection control. Six hundred newborn infants hospitalized longer than 72 hours in Ege University Children's Hospital NICU between January 2008 and December 2010 were prospectively followed for occurrence of device-associated infections (central venous catheter- and umbilical catheter-associated blood stream infections [CVC/UC BSI] and ventilator-associated pneumonia [VAP]). In a total of 10,052 patient days, the VAP rate was 13.76/1000 ventilator days with a ventilator utilization ratio of 0.29, and the CVC/UC BSI rate was 3.8/1000 catheter days with a catheter utilization ratio of 0.24. The CVC/UC BSI rate was lower than national averages, being close to rates reported from developed countries. The VAP rate was higher than the national and international rates and was associated with prolonged mechanical ventilation and very low birth weight. VAP also appeared to be an important risk factor for mortality. The most frequent agents were gram-negative pathogens for VAP and coagulase-negative staphylococci for CVC/UC BSIs, with resistance patterns similar to the previous years. In conclusion, with device utilization rates similar to those in developed countries, our CVC/UC BSI rate was comparable, but the VAP rate was higher than that of the developed countries. Necessary precautions are urgently needed to decrease VAP rates and VAP-related mortality.

Entities:  

Mesh:

Year:  2012        PMID: 22734298

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  8 in total

1.  Risk Factors for Central Line-Associated Bloodstream Infection in Critically Ill Neonates.

Authors:  Heladia García; Belina Romano-Carro; Guadalupe Miranda-Novales; Héctor Jaime González-Cabello; Juan Carlos Núñez-Enríquez
Journal:  Indian J Pediatr       Date:  2019-02-27       Impact factor: 1.967

2.  Outcomes and risk factors of ventilator-associated pneumonia in neonates.

Authors:  Anucha Thatrimontrichai; Natthaka Rujeerapaiboon; Waricha Janjindamai; Supaporn Dissaneevate; Gunlawadee Maneenil; Supika Kritsaneepaiboon; Pattama Tanaanantarak
Journal:  World J Pediatr       Date:  2017-01-25       Impact factor: 2.764

Review 3.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Ventilator-Associated Pneumonia in Neonates Admitted to a Tertiary Care NICU in Bulgaria.

Authors:  Vanya R Rangelova; Ralitsa D Raycheva; Ani K Kevorkyan; Maya B Krasteva; Yordan I Kalchev
Journal:  Front Pediatr       Date:  2022-06-28       Impact factor: 3.569

5.  Preventable contributors to the neonatal healthcare-associated infections: a uni-center analytical study from South India.

Authors:  Usha Rani; Leslie E Lewis; Kiran Chawla; Anup Naha
Journal:  F1000Res       Date:  2022-04-25

6.  Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020.

Authors:  Simon Brinkwirth; Olaniyi Ayobami; Tim Eckmanns; Robby Markwart
Journal:  Euro Surveill       Date:  2021-11

7.  Microbial contamination of manually reprocessed, ready to use ECG lead wire in intensive care units.

Authors:  Trisasi Lestari; Sylvia Ryll; Axel Kramer
Journal:  GMS Hyg Infect Control       Date:  2013-04-29

8.  Increased constituent ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. and a decrease in microflora diversity may be indicators of ventilator-associated pneumonia: a prospective study in the respiratory tracts of neonates.

Authors:  Wei Lu; Jialin Yu; Qing Ai; Dong Liu; Chao Song; Luquan Li
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.